has received an interim stay from the Telangana High Court on income tax reassessment proceedings related to its merger with Dr. Reddy’s Holding Ltd. Dr Reddy’s Laboratories on Saturday said it had received a show cause notice from the income tax authority, with a proposed demand of over ₹2,395 crore related to the merger of Dr Reddy’s Holding Ltd (DRHL) with itself.
- Also read:
is recalling over 20,000 packs of a medication, used to treat asthma and certain types of chronic obstructive pulmonary disease in the US, according to the US health regulator. In its latest Enforcement Report, the US Food and Drug Administration (USFDA) said Cipla USA, Inc., an arm of the Mumbai-based drug major, is recalling Ibuterol Sulfate Inhalation Aerosol.
Biocon Pharma Ltd, a wholly-owned subsidiary of , has received tentative approval from the US Food and Drug Administration for its ANDA for Sitagliptin Tablets USP, in 25 mg, 50 mg and 100 mg strengths. Sitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. The approval will further strengthen Biocon’s portfolio of vertically integrated drug products.